ATROPINE AND DEMEROL Drug Patent Profile
✉ Email this page to a colleague
When do Atropine And Demerol patents expire, and when can generic versions of Atropine And Demerol launch?
Atropine And Demerol is a drug marketed by Abbvie and is included in three NDAs.
The generic ingredient in ATROPINE AND DEMEROL is atropine sulfate; meperidine hydrochloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; meperidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATROPINE AND DEMEROL?
- What are the global sales for ATROPINE AND DEMEROL?
- What is Average Wholesale Price for ATROPINE AND DEMEROL?
Summary for ATROPINE AND DEMEROL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| DailyMed Link: | ATROPINE AND DEMEROL at DailyMed |
US Patents and Regulatory Information for ATROPINE AND DEMEROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | ATROPINE AND DEMEROL | atropine sulfate; meperidine hydrochloride | INJECTABLE;INJECTION | 087853-001 | Nov 26, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | ATROPINE AND DEMEROL | atropine sulfate; meperidine hydrochloride | INJECTABLE;INJECTION | 087847-001 | Nov 26, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | ATROPINE AND DEMEROL | atropine sulfate; meperidine hydrochloride | INJECTABLE;INJECTION | 087848-001 | Nov 26, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
